Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

NCT04515238

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hamatologische/Onkologische Gemeinschaftspraxis Augsburg, Germany
  • Universitätsklinik Köln Cologne, Germany
  • Onkologische Schwerpunktpraxis Esslingen am Neckar, Germany
  • Evangelische Krankenhaus Hamm Hamm, Germany
View Trial Details
Active, Not Recruiting

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

NCT02577926

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Mannheim, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Klinik für Innere Medizin III Ulm, Baden-Wurttemberg, Germany
  • Rems-Murr Klinikum Winnenden Winnenden, Baden-Wurttemberg, Germany
  • Studienzentrum Aschaffenburg Aschaffenburg, Bavaria, Germany
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of 3D189 in Patients With Hematologic Malignancies

NCT05320809

Conditions
Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital Of Nanchang University Nanchang, Jiangxi, China
  • Shengjing Hospital of China Medical Shengyang, Liaoning, China
  • Blood Disease Hospital , Chinese Academy of Medical Science Tianjing, China
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT04649073

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tokai University Hospital Isehara-shi, Japan
  • Nagoya City University Hospital Nagoya, Japan
  • National Hospital Organization Okayama Medical Center Okayama, Japan
  • Sapporo Medical University Hospital Sapporo, Japan
View Trial Details

Related conditions